United States Sarcopenia Treatments Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Sarcopenia Treatments Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Sarcopenia Treatments Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Sarcopenia Treatments Overall Market Size
2.1 United States Sarcopenia Treatments Market Size: 2021 VS 2027
2.2 United States Sarcopenia Treatments Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Sarcopenia Treatments Players in United States Market
3.2 Top United States Sarcopenia Treatments Companies Ranked by Revenue
3.3 United States Sarcopenia Treatments Revenue by Companies
3.4 Top 3 and Top 5 Sarcopenia Treatments Companies in United States Market, by Revenue in 2020
3.5 Companies Sarcopenia Treatments Product Type
3.6 Tier 1, Tier 2 and Tier 3 Sarcopenia Treatments Players in United States Market
3.6.1 List of Tier 1 Sarcopenia Treatments Companies in United States
3.6.2 List of Tier 2 and Tier 3 Sarcopenia Treatments Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Sarcopenia Treatments Market Size Markets, 2021 & 2027
4.1.2 Protein Supplement
4.1.3 Calcium Supplement
4.1.4 Other
4.2 By Type - United States Sarcopenia Treatments Revenue & Forecasts
4.2.1 By Type - United States Sarcopenia Treatments Revenue, 2016-2021
4.2.2 By Type - United States Sarcopenia Treatments Revenue, 2022-2027
4.2.3 By Type - United States Sarcopenia Treatments Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Sarcopenia Treatments Market Size, 2021 & 2027
5.1.2 Online Pharmacies
5.1.3 Retail Pharmacies
5.2 By Application - United States Sarcopenia Treatments Revenue & Forecasts
5.2.1 By Application - United States Sarcopenia Treatments Revenue, 2016-2021
5.2.2 By Application - United States Sarcopenia Treatments Revenue, 2022-2027
5.2.3 By Application - United States Sarcopenia Treatments Revenue Market Share, 2016-2027
6 Sarcopenia Treatments Companies Profiles
6.1 Abbott Laboratories
6.1.1 Abbott Laboratories Company Details
6.1.2 Abbott Laboratories Business Overview
6.1.3 Abbott Laboratories Sarcopenia Treatments Introduction
6.1.4 Abbott Laboratories Sarcopenia Treatments Revenue in United States Market (2016-2021)
6.1.5 Abbott Laboratories Recent Developments
6.2 Nestlé
6.2.1 Nestlé Company Details
6.2.2 Nestlé Business Overview
6.2.3 Nestlé Sarcopenia Treatments Introduction
6.2.4 Nestlé Sarcopenia Treatments Revenue in United States Market (2016-2021)
6.2.5 Nestlé Recent Developments
6.3 Pfizer
6.3.1 Pfizer Company Details
6.3.2 Pfizer Business Overview
6.3.3 Pfizer Sarcopenia Treatments Introduction
6.3.4 Pfizer Sarcopenia Treatments Revenue in United States Market (2016-2021)
6.3.5 Pfizer Recent Developments
6.4 Amway
6.4.1 Amway Company Details
6.4.2 Amway Business Overview
6.4.3 Amway Sarcopenia Treatments Introduction
6.4.4 Amway Sarcopenia Treatments Revenue in United States Market (2016-2021)
6.4.5 Amway Recent Developments
6.5 By-health
6.5.1 By-health Company Details
6.5.2 By-health Business Overview
6.5.3 By-health Sarcopenia Treatments Introduction
6.5.4 By-health Sarcopenia Treatments Revenue in United States Market (2016-2021)
6.5.5 By-health Recent Developments
6.6 Usana
6.6.1 Usana Company Details
6.6.2 Usana Business Overview
6.6.3 Usana Sarcopenia Treatments Introduction
6.6.4 Usana Sarcopenia Treatments Revenue in United States Market (2016-2021)
6.6.5 Usana Recent Developments
6.7 A&Z Pharmaceutical
6.7.1 A&Z Pharmaceutical Company Details
6.7.2 A&Z Pharmaceutical Business Overview
6.7.3 A&Z Pharmaceutical Sarcopenia Treatments Introduction
6.7.4 A&Z Pharmaceutical Sarcopenia Treatments Revenue in United States Market (2016-2021)
6.7.5 A&Z Pharmaceutical Recent Developments
6.8 GlaxoSmithKline
6.8.1 GlaxoSmithKline Company Details
6.8.2 GlaxoSmithKline Business Overview
6.8.3 GlaxoSmithKline Sarcopenia Treatments Introduction
6.8.4 GlaxoSmithKline Sarcopenia Treatments Revenue in United States Market (2016-2021)
6.8.5 GlaxoSmithKline Recent Developments
6.9 Bayer
6.9.1 Bayer Company Details
6.9.2 Bayer Business Overview
6.9.3 Bayer Sarcopenia Treatments Introduction
6.9.4 Bayer Sarcopenia Treatments Revenue in United States Market (2016-2021)
6.9.5 Bayer Recent Developments
6.10 H&H
6.10.1 H&H Company Details
6.10.2 H&H Business Overview
6.10.3 H&H Sarcopenia Treatments Introduction
6.10.4 H&H Sarcopenia Treatments Revenue in United States Market (2016-2021)
6.10.5 H&H Recent Developments
6.11 Blackmores
6.11.1 Blackmores Company Details
6.11.2 Blackmores Business Overview
6.11.3 Blackmores Sarcopenia Treatments Introduction
6.11.4 Blackmores Sarcopenia Treatments Revenue in United States Market (2016-2021)
6.11.5 Blackmores Recent Developments
6.12 Zhendong Group
6.12.1 Zhendong Group Company Details
6.12.2 Zhendong Group Business Overview
6.12.3 Zhendong Group Sarcopenia Treatments Introduction
6.12.4 Zhendong Group Sarcopenia Treatments Revenue in United States Market (2016-2021)
6.12.5 Zhendong Group Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of TablesTable 1. Sarcopenia Treatments Market Opportunities & Trends in United States Market
Table 2. Sarcopenia Treatments Market Drivers in United States Market
Table 3. Sarcopenia Treatments Market Restraints in United States Market
Table 4. Key Players of Sarcopenia Treatments in United States Market
Table 5. Top Sarcopenia Treatments Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Sarcopenia Treatments Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Sarcopenia Treatments Revenue Share by Companies, 2016-2021
Table 8. Companies Sarcopenia Treatments Product Type
Table 9. List of Tier 1 Sarcopenia Treatments Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Sarcopenia Treatments Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States Sarcopenia Treatments Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Sarcopenia Treatments Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Sarcopenia Treatments Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States Sarcopenia Treatments Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Sarcopenia Treatments Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Sarcopenia Treatments Revenue (US$, Mn), 2022-2027
Table 17. Abbott Laboratories Company Details
Table 18. Abbott Laboratories Business Overview
Table 19. Abbott Laboratories Sarcopenia Treatments Product
Table 20. Abbott Laboratories Sarcopenia Treatments Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Abbott Laboratories Recent Developments
Table 22. Nestlé Company Details
Table 23. Nestlé Business Overview
Table 24. Nestlé Sarcopenia Treatments Product
Table 25. Nestlé Sarcopenia Treatments Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. Nestlé Recent Developments
Table 27. Pfizer Company Details
Table 28. Pfizer Business Overview
Table 29. Pfizer Sarcopenia Treatments Product
Table 30. Pfizer Sarcopenia Treatments Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. Pfizer Recent Developments
Table 32. Amway Company Details
Table 33. Amway Business Overview
Table 34. Amway Sarcopenia Treatments Product
Table 35. Amway Sarcopenia Treatments Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. Amway Recent Developments
Table 37. By-health Company Details
Table 38. By-health Business Overview
Table 39. By-health Sarcopenia Treatments Product
Table 40. By-health Sarcopenia Treatments Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. By-health Recent Developments
Table 42. Usana Company Details
Table 43. Usana Business Overview
Table 44. Usana Sarcopenia Treatments Product
Table 45. Usana Sarcopenia Treatments Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. Usana Recent Developments
Table 47. A&Z Pharmaceutical Company Details
Table 48. A&Z Pharmaceutical Business Overview
Table 49. A&Z Pharmaceutical Sarcopenia Treatments Product
Table 50. A&Z Pharmaceutical Sarcopenia Treatments Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. A&Z Pharmaceutical Recent Developments
Table 52. GlaxoSmithKline Company Details
Table 53. GlaxoSmithKline Business Overview
Table 54. GlaxoSmithKline Sarcopenia Treatments Product
Table 55. GlaxoSmithKline Sarcopenia Treatments Revenue in United States Market (2016-2021) & (US$ Million)
Table 56. GlaxoSmithKline Recent Developments
Table 57. Bayer Company Details
Table 58. Bayer Business Overview
Table 59. Bayer Sarcopenia Treatments Product
Table 60. Bayer Sarcopenia Treatments Revenue in United States Market (2016-2021) & (US$ Million)
Table 61. Bayer Recent Developments
Table 62. H&H Company Details
Table 63. H&H Business Overview
Table 64. H&H Sarcopenia Treatments Product
Table 65. H&H Sarcopenia Treatments Revenue in United States Market (2016-2021) & (US$ Million)
Table 66. H&H Recent Developments
Table 67. Blackmores Company Details
Table 68. Blackmores Business Overview
Table 69. Blackmores Sarcopenia Treatments Product
Table 70. Blackmores Sarcopenia Treatments Revenue in United States Market (2016-2021) & (US$ Million)
Table 71. Blackmores Recent Developments
Table 72. Zhendong Group Company Details
Table 73. Zhendong Group Business Overview
Table 74. Zhendong Group Sarcopenia Treatments Product
Table 75. Zhendong Group Sarcopenia Treatments Revenue in United States Market (2016-2021) & (US$ Million)
Table 76. Zhendong Group Recent Developments
List of FiguresFigure 1. Sarcopenia Treatments Segment by Type
Figure 2. Sarcopenia Treatments Segment by Application
Figure 3. United States Sarcopenia Treatments Market Overview: 2020
Figure 4. United States Sarcopenia Treatments Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Sarcopenia Treatments Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Sarcopenia Treatments Revenue in 2020
Figure 7. By Type - United States Sarcopenia Treatments Revenue Market Share, 2016-2027
Figure 8. By Application - United States Sarcopenia Treatments Revenue Market Share, 2016-2027
Figure 9. Abbott Laboratories Sarcopenia Treatments Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Nestlé Sarcopenia Treatments Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Pfizer Sarcopenia Treatments Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Amway Sarcopenia Treatments Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. By-health Sarcopenia Treatments Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Usana Sarcopenia Treatments Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. A&Z Pharmaceutical Sarcopenia Treatments Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. GlaxoSmithKline Sarcopenia Treatments Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Bayer Sarcopenia Treatments Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. H&H Sarcopenia Treatments Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 19. Blackmores Sarcopenia Treatments Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 20. Zhendong Group Sarcopenia Treatments Revenue Year Over Year Growth (US$, Mn) & (2016-2021)